Teresa Nelson, MS is a biostatistician with over 15 years experience in the medical device industry in the areas of statistics and health economics. She has extensive experience in study design strategy - analysis of data, interpretation of results and writing of reports for government regulatory bodies and commercial insurers. She has worked on projects in all phases of research from feasibility or pre-market to those supporting market approval and and post-market and outcomes studies. She has FDA panel experience and successfully negotiated many FDA IDE approvals including some recent success with adaptive study designs.

Her experience in health economics includes outcomes studies and cost-effectiveness analyses using healthcare claims analysis and economic modeling. Ms. Nelson has utilized both Bayesian and Frequentist methods in clinical and health economics studies, including Bayesian cost-effectiveness analyses, meta-analysis and evidence synthesis. She has helped many clients determine which methodology is most advantageous for their project, especially from the perspective of the required sample size.